Arterial smooth muscle cells express platelet-derived growth factor (PDGF) A chain mRNA, secrete a PDGF-like mitogen, and bind exogenous PDGF in a phenotype- and growth state-dependent manner

Adult rat arterial smooth muscle cells are shown to express platelet- derived growth factor (PDGF) A chain mRNA, to secrete a PDGF-like mitogen, and to bind exogenous PDGF in a phenotype- and growth state- dependent manner. In the intact aortic media, where the cells are in a contractile phenotype, only minute amounts of PDGF A chain and no B chain (c-sis) RNA were detected. After cultivation and modulation of the cells into a synthetic phenotype, the A chain gene was distinctly expressed, whereas the B chain gene remained unexpressed. Cells kept in serum-free medium on a substrate of plasma fibronectin showed high levels of A chain RNA and high PDGF receptor activity, but did not secrete detectable amounts of PDGF-like mitogen. After exposure to PDGF, which is itself sufficient to initiate DNA synthesis and mitosis in these cells, a PDGF-like mitogen was released into the extracellular medium. Concomitantly, the amount of A chain transcripts per cell and the ability of the cells to bind radioactive PDGF decreased. Similarly, smooth muscle cells initially grown in the presence of serum released more PDGF-like mitogen, contained fewer A chain transcripts, and bound more radioactive PDGF in proliferating than in stationary cultures. The findings confirm the notion that adult rat arterial smooth muscle cells are able to promote their own growth in an autocrine or paracrine manner. Furthermore, they reveal some basic principles in the control of this process.

[1]  G. Owens,et al.  Expression of smooth muscle-specific alpha-isoactin in cultured vascular smooth muscle cells: relationship between growth and cytodifferentiation , 1986, The Journal of cell biology.

[2]  Stephen M. Schwartz,et al.  Developmentally regulated production of platelet-derived growth factor-like molecules , 1984, Nature.

[3]  M. Lavin,et al.  Platelet-derived growth factor receptors form a high affinity state in membrane preparations. Kinetics and affinity cross-linking studies. , 1984, The Journal of biological chemistry.

[4]  M. Sporn,et al.  Autocrine secretion and malignant transformation of cells. , 1980, The New England journal of medicine.

[5]  R. Ross The pathogenesis of atherosclerosis--an update. , 1986, The New England journal of medicine.

[6]  M. Reitz,et al.  Transformation of NIH 3T3 cells by a human c-sis cDNA clone , 1984, Nature.

[7]  P. Thomas,et al.  Hybridization of denatured RNA and small DNA fragments transferred to nitrocellulose. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[8]  J. Thyberg,et al.  Phenotype modulation in primary cultures of smooth-muscle cells from rat aorta. Synthesis of collagen and elastin. , 1986, Differentiation; research in biological diversity.

[9]  J. Vandekerckhove,et al.  Actin expression in smooth muscle cells of rat aortic intimal thickening, human atheromatous plaque, and cultured rat aortic media. , 1984, The Journal of clinical investigation.

[10]  M. Hosang Suramin binds to platelet‐derived growth factor and inhibits its biological activity , 1985, Journal of cellular biochemistry.

[11]  R F Doolittle,et al.  Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor. , 1983, Science.

[12]  N. Ringertz,et al.  Density‐dependent arrest of DNA replication is accompanied by decreased levels of c‐myc mRNA in myogenic but not in differentiation‐defective myoblasts , 1985, Journal of cellular physiology.

[13]  K. Weber,et al.  Co-existence of vimentin and desmin type intermediate filaments in a subpopulation of adult rat vascular smooth muscle cells growing in primary culture. , 1982, Experimental cell research.

[14]  C. Heldin,et al.  Specific receptors for platelet-derived growth factor on cells derived from connective tissue and glia. , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[15]  V. Freedman,et al.  Tumorigenicity of virus-transformed cells in nude mice is correlated specifically with anchorage independent growth in vitro. , 1975, Proceedings of the National Academy of Sciences of the United States of America.

[16]  C. Heldin,et al.  Rat skeletal myoblasts and arterial smooth muscle cells express the gene for the A chain but not the gene for the B chain (c-sis) of platelet-derived growth factor (PDGF) and produce a PDGF-like protein. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[17]  C. Heldin,et al.  The phenotypic characteristics of simian sarcoma virus‐transformed human fibroblasts suggest that the v‐sis gene product acts solely as a PDGF receptor agonist in cell transformation. , 1986, The EMBO journal.

[18]  R. Eddy,et al.  cDNA sequence and chromosomal localization of human platelet-derived growth factor A-chain and its expression in tumour cell lines , 1986, Nature.

[19]  C. Stiles,et al.  Purification of human platelet-derived growth factor. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[20]  J. Thyberg,et al.  Phenotype modulation in primary cultures of arterial smooth-muscle cells: reorganization of the cytoskeleton and activation of synthetic activities. , 1985, Differentiation; research in biological diversity.

[21]  R. Ross,et al.  Production of platelet-derived growth factor-like molecules by cultured arterial smooth muscle cells accompanies proliferation after arterial injury. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[22]  C. Heldin,et al.  Demonstration of an antibody against platelet-derived growth factor. , 1981, Experimental cell research.

[23]  C. Auffray,et al.  Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. , 2005, European journal of biochemistry.

[24]  M. Sporn,et al.  Type beta transforming growth factor in human platelets: release during platelet degranulation and action on vascular smooth muscle cells , 1986, The Journal of cell biology.

[25]  R. Alexander,et al.  Myosin in cultured vascular smooth muscle cells: immunofluorescence and immunochemical studies of alterations in antigenic expression , 1984, The Journal of cell biology.

[26]  R. Ross,et al.  Phenotype-dependent response of cultured aortic smooth muscle to serum mitogens , 1981, The Journal of cell biology.

[27]  C. Heldin,et al.  Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[28]  H. Boedtker,et al.  RNA molecular weight determinations by gel electrophoresis under denaturing conditions, a critical reexamination. , 1977, Biochemistry.

[29]  E. Engvall,et al.  Fibronectin: purification, immunochemical properties, and biological activities. , 1982, Methods in enzymology.

[30]  A. Daoud,et al.  Association of DNA synthesis and apparent dedifferentiation of aortic smooth muscle cells in vitro. , 1970, Experimental and molecular pathology.

[31]  R. Ross,et al.  Synthesis of connective tissue macromolecules by smooth muscle. , 1979, International review of connective tissue research.

[32]  C. Heldin,et al.  Growth factors: Mechanism of action and relation to oncogenes , 1984, Cell.

[33]  P. Benya,et al.  Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels , 1982, Cell.

[34]  R. Ross,et al.  Platelet‐derived growth factor: Morphologic and biochemical studies of binding, internalization, and degradation , 1984, Journal of cellular physiology.

[35]  G. Gabbiani,et al.  Cytoskeletal remodeling of rat aortic smooth muscle cells in vitro: relationships to culture conditions and analogies to in vivo situations. , 1986, Journal of submicroscopic cytology.

[36]  R. Ross,et al.  The biology of platelet-derived growth factor , 1986, Cell.

[37]  C. Heldin,et al.  Interaction of platelet-derived growth factor with its fibroblast receptor. Demonstration of ligand degradation and receptor modulation. , 1982, The Journal of biological chemistry.

[38]  Paul Stroobant,et al.  Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus , 1983, Nature.

[39]  C. Heldin,et al.  Surface binding and internalization of platelet-derived growth factor in human fibroblasts. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[40]  S. Schwartz,et al.  Replication of smooth muscle cells in vascular disease. , 1986, Circulation research.

[41]  C. Heldin,et al.  Arterial smooth muscle cells in primary culture produce a platelet-derived growth factor-like protein. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[42]  C. Heldin,et al.  A glioma-derived analog to platelet-derived growth factor: demonstration of receptor competing activity and immunological crossreactivity. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[43]  J. Thyberg,et al.  Phenotype modulation in primary cultures of arterial smooth muscle cells. On the role of platelet-derived growth factor. , 1983, Differentiation; research in biological diversity.

[44]  J. Thyberg,et al.  Plasma fibronectin promotes modulation of arterial smooth-muscle cells from contractile to synthetic phenotype. , 1987, Differentiation; research in biological diversity.

[45]  M. Melamed,et al.  Simultaneous staining of ribonucleic and deoxyribonucleic acids in unfixed cells using acridine orange in a flow cytofluorometric system. , 1977, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[46]  R. Ross,et al.  The smooth muscle cell in culture. , 1979, Physiological reviews.